Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

France Extracorporeal Membrane Oxygenation Machine Market

ID: MRFR/MED/49073-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026

France Extracorporeal Membrane Oxygenation Machine Market Research Report: Size, Share, Trend Analysis By Applications (Cardiac Support, Respiratory Support, Cardiopulmonary Bypass), By End Users (Hospitals, Ambulatory Surgical Centers, Home Care Settings), By Product Type (Venoarterial ECMO, Venovenous ECMO, Arteriovenous ECMO) andBy Component (Membrane Oxygenator, Blood Pumps, Heat Exchangers) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

France Extracorporeal Membrane Oxygenation Machine Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Application (USD Million) | |
      1. 4.1.1 Cardiac Support | |
      2. 4.1.2 Respiratory Support | |
      3. 4.1.3 Cardiopulmonary Bypass |
    2. 4.2 Healthcare, BY End User (USD Million) | |
      1. 4.2.1 Hospitals | |
      2. 4.2.2 Ambulatory Surgical Centers | |
      3. 4.2.3 Home Care Settings |
    3. 4.3 Healthcare, BY Product Type (USD Million) | |
      1. 4.3.1 Venoarterial ECMO | |
      2. 4.3.2 Venovenous ECMO | |
      3. 4.3.3 Arteriovenous ECMO |
    4. 4.4 Healthcare, BY Component (USD Million) | |
      1. 4.4.1 Membrane Oxygenator | |
      2. 4.4.2 Blood Pumps | |
      3. 4.4.3 Heat Exchangers 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Medtronic (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Getinge (SE) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 LivaNova (GB) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Fresenius SE (DE) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Terumo Corporation (JP) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Maquet (DE) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Nipro Corporation (JP) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Cleveland Medical Devices (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 FRANCE MARKET ANALYSIS BY APPLICATION |
    6. 6.3 FRANCE MARKET ANALYSIS BY END USER |
    7. 6.4 FRANCE MARKET ANALYSIS BY PRODUCT TYPE |
    8. 6.5 FRANCE MARKET ANALYSIS BY COMPONENT |
    9. 6.6 KEY BUYING CRITERIA OF HEALTHCARE |
    10. 6.7 RESEARCH PROCESS OF MRFR |
    11. 6.8 DRO ANALYSIS OF HEALTHCARE |
    12. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    13. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    14. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE |
    15. 6.12 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
    16. 6.13 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million) |
    17. 6.14 HEALTHCARE, BY END USER, 2024 (% SHARE) |
    18. 6.15 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million) |
    19. 6.16 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE) |
    20. 6.17 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million) |
    21. 6.18 HEALTHCARE, BY COMPONENT, 2024 (% SHARE) |
    22. 6.19 HEALTHCARE, BY COMPONENT, 2024 TO 2035 (USD Million) |
    23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    24. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    25. 7.2 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million) | |
      2. 7.2.2 BY END USER, 2025-2035 (USD Million) | |
      3. 7.2.3 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
      4. 7.2.4 BY COMPONENT, 2025-2035 (USD Million) |
    26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.3.1 |
    27. 7.4 ACQUISITION/PARTNERSHIP | |

France Healthcare Market Segmentation

Healthcare By Application (USD Million, 2025-2035)

  • Cardiac Support
  • Respiratory Support
  • Cardiopulmonary Bypass

Healthcare By End User (USD Million, 2025-2035)

  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care Settings

Healthcare By Product Type (USD Million, 2025-2035)

  • Venoarterial ECMO
  • Venovenous ECMO
  • Arteriovenous ECMO

Healthcare By Component (USD Million, 2025-2035)

  • Membrane Oxygenator
  • Blood Pumps
  • Heat Exchangers

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions